Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets

Cell Transplantation

Volumn 18, Issue 8, 2009, Pages 833-845

  Johnson, James D ^a   Ao, Ziliang ^a   Ao, Peter ^a   Li, Hong ^a   Dai, Long Jun ^a   He, Zehua ^a   Tee, May ^a   Potter, Kathryn J ^b   Klimek, Agnieszka M ^a,b   Meloche, R Mark ^a   Thompson, David M ^a   Verchere, C Bruce ^a,b   Warnock, Garth L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes; FK506; Islet transplantation; Mycophenolate mofetil; Rapamycin

Indexed keywords

CASPASE 3; EXENDIN 4; GLUCOSE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; ENDOPLASMIC RETICULUM STRESS; EXOCYTOSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DRUG EVALUATION, PRECLINICAL; GLUCOSE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; MICE, SCID; MYCOPHENOLIC ACID; SIROLIMUS; TACROLIMUS;

MUS; RODENTIA;

EID: 72049110972     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X471198     Document Type: Article

References (58)

1. Ahern, G. P.; Junankar, P. R.; Dulhunty, A. F. Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506. FEBS Lett. 352:369-374; 1994.
2. Basadonna, G.; Montorsi, F.; Kakizaki, K.; Merrell, R. C. Cyclosporin A and islet function. Am. J. Surg. 156:191-193; 1988.
3. Berribi, C.; Loirat, C.; Jacqz-Aigrain, E. Mycophenolate mofetil may induce apoptosis in duodenal villi. Pediatr. Nephrol. 14:177-178; 2000.
4. Braun, M.; Wendt, A.; Buschard, K.; Salehi, A.; Sewing, S.; Gromada, J.; Rorsman, P. GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin. J. Physiol. 559:397-409; 2004. (Pubitemid 39263807)
5. Bueno, O. F.; Brandt, E. B.; Rothenberg, M. E.; Molkentin, J. D. Defective T cell development and function in calcineurin A beta-deficient mice. Proc. Natl. Acad. Sci. USA 99:9398-9403; 2002.
6. Bussiere, C. T.; Lakey, J. R.; Shapiro, A. M.; Korbutt, G. S. The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells. Diabetologia 49:2341-2349; 2006.
7. 2+ flux. Cell 83:463-472; 1995.
8. Citterio, C.; Vichi, A.; Pacheco-Rodriguez, G.; Aponte, A. M.; Moss, J.; Vaughan, M. Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1. Proc. Natl. Acad. Sci. USA 105:2877-2882; 2008.
9. D'Amico, E.; Hui, H.; Khoury, N.; Di Mario, U.; Perfetti, R. Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs. J. Mol. Endocrinol. 34:377-390; 2005.
10. Desai, N. M.; Goss, J. A.; Deng, S.; Wolf, B. A.; Markmann, E.; Palanjian, M.; Shock, A. P.; Feliciano, S.; Brunicardi, F. C.; Barker, C. F.; Naji, A.; Markmann, J. F. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: Local immunosuppression or islet toxicity? Transplantation 76:1623-1625; 2003.
11. Dror, V.; Nguyen, V.; Walia, P.; Kalynyak, T. B.; Hill, J. A.; Johnson, J. D. Notch signalling suppresses apoptosis in adult human and mouse pancreatic islet cells. Diabetologia 50:2504-2515; 2007.
12. Drucker, D. J. Glucagon-like peptide-1 and the islet beta-cell: Augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145-5148; 2003.
13. Eizirik, D. L.; Cardozo, A. K.; Cnop, M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29:42-61; 2008.
14. Fabian, M. C.; Lakey, J. R.; Rajotte, R. V.; Kneteman, N. M. The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies. Transplantation 56:1137-1142; 1993.
15. Froud, T.; Baidal, D. A.; Ponte, G.; Ferreira, J. V.; Ricordi, C.; Alejandro, R. Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF. Cell Transplant. 15:613-620; 2006. (Pubitemid 44904673)
16. Froud, T.; Faradji, R. N.; Pileggi, A.; Messinger, S.; Baidal, D. A.; Ponte, G. M.; Cure, P. E.; Monroy, K.; Mendez, A.; Selvaggi, G.; Ricordi, C.; Alejandro, R. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: Safety, efficacy, and metabolic effects. Transplantation 86:36-45; 2008.
17. Gangemi, A.; Salehi, P.; Hatipoglu, B.; Martellotto, J.; Barbaro, B.; Kuechle, J. B.; Qi, M.; Wang, Y.; Pallan, P.; Owens, C.; Bui, J.; West, D.; Kaplan, B.; Benedetti, E.; Oberholzer, J. Islet transplantation for brittle type 1 diabetes: The UIC protocol. Am. J. Transplant. 8:1250-1261; 2008.
18. Gao, R.; Ustinov, J.; Korsgren, O.; Otonkoski, T. Effects of immunosuppressive drugs on in vitro neogenesis of human islets: Mycophenolate mofetil inhibits the proliferation of ductal cells. Am. J. Transplant. 7:1021-1026; 2007.
19. Ghofaili, K. A.; Fung, M.; Ao, Z.; Meloche, M.; Shapiro, R. J.; Warnock, G. L.; Elahi, D.; Meneilly, G. S.; Thompson, D. M. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation 83:24-28; 2007.
20. Gill, D. L.; Ghosh, T. K.; Mullaney, J. M. Calcium signalling mechanisms in endoplasmic reticulum activated by inositol 1,4,5-trisphosphate and GTP. Cell Calcium 10:363-374; 1989.
21. Gleason, C. E.; Lu, D.; Witters, L. A.; Newgard, C. B.; Birnbaum, M. J. The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. J. Biol. Chem. 282:10341-10351; 2007.
22. Heit, J. J.; Apelqvist, A. A.; Gu, X.; Winslow, M. M.; Neilson, J. R.; Crabtree, G. R.; Kim, S. K. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443:345-349; 2006.
23. Johnson, J. D.; Bernal-Mizrachi, E.; Alejandro, E. U.; Han, Z.; Kalynyak, T. B.; Li, H.; Beith, J. L.; Gross, J.; Warnock, G. L.; Townsend, R. R.; Permutt, M. A.; Polonsky, K. S. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc. Natl. Acad. Sci. USA 103:19575-19580; 2006.
24. Johnson, J. D.; Han, Z.; Otani, K.; Ye, H.; Zhang, Y.; Wu, H.; Horikawa, Y.; Misler, S.; Bell, G. I.; Polonsky, K. S. RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. J. Biol. Chem. 279:24794-24802; 2004.
25. Johnson, J. D.; Kuang, S.; Misler, S.; Polonsky, K. S. Ryanodine receptors in human pancreatic beta cells: Localization and effects on insulin secretion. FASEB J. 18:878-880; 2004.
26. Johnson, J. D.; Misler, S. Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells. Proc. Natl. Acad. Sci. USA 99:14566-14571; 2002.
27. Kibbey, R. G.; Pongratz, R. L.; Romanelli, A. J.; Wollheim, C. B.; Cline, G. W.; Shulman, G. I. Mitochondrial GTP regulates glucose-stimulated insulin secretion. Cell Metab. 5:253-264; 2007.
28. Kneteman, N. M.; Marchetti, P.; Tordjman, K.; Bier, D. M.; Santiago, J. V.; Swanson, C. J.; Olack, B. J.; Scharp, D. W. Effects of cyclosporine on insulin-secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants. Surgery 111:430-437; 1992.
29. Luciani, D. S.; Johnson, J. D. Acute effects of insulin on beta-cells from transplantable human islets. Mol. Cell. Endocrinol. 241:88-98; 2005.
30. Marcelli-Tourvieille, S.; Hubert, T.; Moerman, E.; Gmyr, V.; Kerr-Conte, J.; Nunes, B.; Dherbomez, M.; Vandewalle, B.; Pattou, F.; Vantyghem, M. C. In vivo and in vitro effect of sirolimus on insulin secretion. Transplantation 83:532-538; 2007.
31. Marchetti, P.; Navalesi, R. The metabolic effects of cyclosporin and tacrolimus. J. Endocrinol. Invest. 23:482-490; 2000.
32. McDaniel, M. L.; Marshall, C. A.; Pappan, K. L.; Kwon, G. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic beta-cells. Diabetes 51:2877-2885; 2002.
33. Mita, A.; Ricordi, C.; Miki, A.; Barker, S.; Haertter, R.; Hashikura, Y.; Miyagawa, S.; Burke, 3rd, G. W.; Inverardi, L.; Ichii, H. Anti-proinflammatory effects of sirolimus on human islet preparations. Transplantation 86:46-53; 2008.
34. Nir, T.; Melton, D. A.; Dor, Y. Recovery from diabetes in mice by beta cell regeneration. J. Clin. Invest. 117:2553-2561; 2007.
35. Oyadomari, S.; Koizumi, A.; Takeda, K.; Gotoh, T.; Akira, S.; Araki, E.; Mori, M. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 109:525-532; 2002.
36. Paty, B. W.; Harmon, J. S.; Marsh, C. L.; Robertson, R. P. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 73:353-357; 2002.
37. Penfornis, A.; Kury-Paulin, S. Immunosuppressive drug-induced diabetes. Diabetes Metab. 32:539-546; 2006.
38. Polastri, L.; Galbiati, F.; Bertuzzi, F.; Fiorina, P.; Nano, R.; Gregori, S.; Aldrighetti, L.; Pozza, G.; Secchi, A.; Adorini, L.; Davalli, A. M. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol. 39:229-233; 2002.
39. Redmon, J. B.; Olson, L. K.; Armstrong, M. B.; Greene, M. J.; Robertson, R. P. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J. Clin. Invest. 98:2786-2793; 1996.
40. Reffet, S.; Thivolet, C. Immunology of pancreatic islet transplantation. Diabetes Metab. 32:523-526; 2006.
41. Ricordi, C.; Zeng, Y. J.; Alejandro, R.; Tzakis, A.; Venkataramanan, R.; Fung, J.; Bereiter, D.; Mintz, D. H.; Starzl, T. E. In vivo effect of FK506 on human pancreatic islets. Transplantation 52:519-522; 1991.
42. Ruvinsky, I.; Sharon, N.; Lerer, T.; Cohen, H.; Stolovich-Rain, M.; Nir, T.; Dor, Y.; Zisman, P.; Meyuhas, O. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19:2199-2211; 2005. (Pubitemid 41330321)
43. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Bigam, D.; Alfadhli, E.; Kneteman, N. M.; Lakey, J. R.; Shapiro, A. M. Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069; 2005.
44. Salvadori, M.; Bertoni, E.; Rosati, A.; Zanazzi, M. Post-transplant diabetes mellitus. J. Nephrol. 16:626-634; 2003.
45. Sandberg, J. O.; Andersson, A.; Sandler, S. Exposure of rat pancreatic islets to RS-61443 inhibits beta-cell function. Transplantation 56:1197-1201; 1993. (Pubitemid 23348700)
46. Shapiro, A. M.; Gallant, H. L.; Hao, E. G.; Lakey, J. R.; McCready, T.; Rajotte, R. V.; Yatscoff, R. W.; Kneteman, N. M. The portal immunosuppressive storm: Relevance to islet transplantation? Ther. Drug Monit. 27:35-37; 2005.
47. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
48. Takebe, N.; Cheng, X.; Fandy, T. E.; Srivastava, R. K.; Wu, S.; Shankar, S.; Bauer, K.; Shaughnessy, J.; Tricot, G. IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol. Cancer Ther. 5:457-466; 2006.
49. Tamura, K.; Fujimura, T.; Tsutsumi, T.; Nakamura, K.; Ogawa, T.; Atumaru, C.; Hirano, Y.; Ohara, K.; Ohtsuka, K.; Shimomura, K.; Kobayashi, M. Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high. Transplant. Proc. 27:357-361; 1995.
50. Tamura, K.; Fujimura, T.; Tsutsumi, T.; Nakamura, K.; Ogawa, T.; Atumaru, C.; Hirano, Y.; Ohara, K.; Ohtsuka, K.; Shimomura, K.; Kobayashi, M. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 59:1606-1613; 1995.
51. Tsunoda, S. M.; Aweeka, F. T. Drug concentration monitoring of immunosuppressive agents: focus on tacrolimus, mycophenolate mofetil and sirolimus. BioDrugs 14:355-369; 2000.
52. Vegso, G.; Sebestyen, A.; Paku, S.; Barna, G.; Hajdu, M.; Toth, M.; Jaray, J.; Kopper, L. Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas. Leuk. Res. 31:1003-1008; 2007.
53. Warnock, G. L.; Meloche, R. M.; Thompson, D.; Shapiro, R. J.; Fung, M.; Ao, Z.; Ho, S.; He, Z.; Dai, L. J.; Young, L.; Blackburn, L.; Kozak, S.; Kim, P. T.; Al-Adra, D.; Johnson, J. D.; Liao, Y. H.; Elliott, T.; Verchere, C. B. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch. Surg. 140:735-744; 2005.
54. Young, D. A.; Nickerson-Nutter, C. L. mTOR-beyond transplantation. Curr. Opin. Pharmacol. 5:418-423; 2005.
55. Yusta, B.; Baggio, L. L.; Estall, J. L.; Koehler, J. A.; Holland, D. P.; Li, H.; Pipeleers, D.; Ling, Z.; Drucker, D. J. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 4:391-406; 2006.
56. Yuste, R.; Majewska, A.; Holthoff, K. From form to function: Calcium compartmentalization in dendritic spines. Nat. Neurosci. 3:653-659; 2000.
57. Zahr, E.; Molano, R. D.; Pileggi, A.; Ichii, H.; Jose, S. S.; Bocca, N.; An, W.; Gonzalez-Quintana, J.; Fraker, C.; Ricordi, C.; Inverardi, L. Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation 84:1576-1583; 2007.
58. Zhang, N.; Su, D.; Qu, S.; Tse, T.; Bottino, R.; Balamurugan, A. N.; Xu, J.; Bromberg, J. S.; Dong, H. H. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes 55:2429-2436; 2006.